Procter & Gamble (PG) shares will be underpinned by the steady fiscal year outlook after "better-than-feared" Q2 results proved to be "good enough," UBS Securities said Wednesday in a report.
"We expect the feasibility of the H2 ramp will continue to be debated to a degree, but in an environment where top and bottom-line momentum for many staples companies is not trending in the right direction, we think the sequential improvement narrative will continue to drive shares higher in the coming months," UBS said.
The UBS earnings estimate for the fiscal year remained at $6.91 a share. Procter & Gamble on Wednesday maintained its fiscal 2025 core EPS guidance of $6.91 to $7.05.
Fiscal Q2 results rose more than expected by analysts, buoyed by revenue gains across the majority of business segments.
UBS maintained its buy rating on Procter & Gamble with a $189 price target.
Price: 165.50, Change: +0.76, Percent Change: +0.46
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。